Home
About Us
Membership
Member Biography

Member Biography

Mohammad Issam Abu-Zaid, MD

Mohammad Issam Abu-Zaid, M.D.

Phone: (317) 944-0920, Patient issues/appointments

Faculty appointments

Assistant Professor, Department of Medicine, Division of Hematology/Oncology, IU School of Medicine
Associate member, Cancer Prevention and Control

I am the principal investigator for the Multiple Myeloma and Plasma Cell dyscrasia Cohort Biobanking Study, an effort supported by the Precision Health Initiative through Indiana CTSI. My future interests are discovery of novel genomic targets that could be targeted therapeutically for patients with multiple myeloma. I also have an interest in cancer survivorship and have participated in several projects through the Platinum Study led by IU Survivorship program.

Long-Term Adverse Health Outcomes in Survivors of Germ Cell Tumors Treated with High Dose ChemotherapyIUSCC-0628

Pilot Investigation of Social and Environmental Risk Factors for Incidence and Outcomes of Multiple Myeloma in The State of IndianaCTO-IUSCC-0724

The Indiana Myeloma RegistryIUSCC-0661

GRAVITAS-309: A Phase 2/3 Study of Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host DiseaseINCB39110-309

AGAVE-201, A Phase 2, Open-label, Randomized, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Axatilimab at 3 Different Doses in Patients with Recurrent or Refractory Active Chronic Graft Versus Host Disease who have Received at least 2 Lines of Systemic TherapyCTO-SNDX-6352-0504

Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ALVR105 (Viralym-M) Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6, and JCV Infection and/or Disease, in High-Risk Patients After Allogeneic Hematopoietic Cell TransplantCTO-ALLOVIR-P-105-202

Long-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel company-sponsored clinical studies.CTO-68284528MMY4002

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients with Hematologic MalignanciesCTO-PRESERVE-I

Global Registry for Long Term Follow up of Patients Participating in Clinical Trials with Posoleucel (ALVR105)CTO-P-105-401

Headlines & highlights

#ResearchCuresCancer

Support Our Research